Discover 1,072 paid clinical trials in Oregon. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oregon provides numerous opportunities for both healthy volunteers and individuals with specific health conditions to get involved in paid medical research. With major research centers in Portland, Eugene, and Salem actively recruiting, participants can access the latest in treatment options and medical innovation.
Filter
1
Filter results
Results: 1,072
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Boston MA, Staten Island NY, New York NY, Newark NJ,
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Home Sleep Therapy for Older Adults With MCI
for
Mild Cognitive Impairment, Sleep,
Location: Eugene OR
Sponsor: Brain Electrophysiology Laboratory Company
Sex: All
Age: 40 - 70+
Code: NCT05771844
Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: Boston MA, The Bronx NY, New Castle DE, Baltimore MD,
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Halifax, Boston MA, Norwich CT, New Haven CT, Quebec,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase3, Recruiting
Active & Responsive
BBD Longitudinal Study of Osteogenesis Imperfecta
for
Osteogenesis Imperfecta
Location: New York NY, Montreal, Wilmington DE, Baltimore MD,
Sponsor: Baylor College of Medicine
Sex: All
Age: 0+
Code: NCT02432625
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Boston MA, Lebanon NH, Great Neck NY, New York NY,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase3, Recruiting
Active & Responsive
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
for
X-linked Retinoschisis
Location: Boston MA, New York NY, Philadelphia PA, Durham NC,
Sponsor: Atsena Therapeutics Inc.
Sex: All
Age: 6+
Code: NCT05878860
Phase3, Recruiting
Active & Responsive
An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO Trial
for
Primary Brain Neoplasm
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07278440
Recruiting
Active & Responsive
A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
for
Stage I Pancreatic Cancer AJCC v8,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT07651358
Recruiting
Active & Responsive
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
for
Solid Tumors
Location: St. Petersburg FL, Germantown TN, Rochester MN,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT07415031
Phase2, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07496567
Phase2, Phase3, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
for
HR+ HER2- Breast Cancer
Location: Nashville TN, Austin TX, San Antonio TX, Lone Tree CO,
Sponsor: Faeth Therapeutics
Sex: All
Age: 18+
Code: NCT07558733
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Boston MA, Hackensack NJ, Tampa FL, Atlanta GA,
Sponsor: Kelonia Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07075185
Phase1, Recruiting
Active & Responsive
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
for
Gynecologic Cancers, Breast Cancer
Location: Philadelphia PA, Corvallis OR
Sponsor: Oregon State University
Sex: Female
Age: 18+
Code: NCT07055854
Phase1, Recruiting
Active & Responsive
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
for
Immune Thrombocytopenic Purpura (ITP)
Location: Boston MA, Portland OR
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06948318
Phase3, Recruiting
Active & Responsive
FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors
for
Solid Tumor
Location: Portland OR
Sponsor: Axcynsis Therapeutics Pte Ltd
Sex: All
Age: 18+
Code: NCT06809114
Phase1, Recruiting
Active & Responsive
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
for
Hematopoietic and Lymphatic System Neoplasm
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06895473
Phase2, Recruiting
Active & Responsive
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial
for
Mantle Cell Lymphoma
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute
Sex: All
Age: 18+
Code: NCT06357676
Phase1, Phase2, Recruiting
Active & Responsive
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Chapel Hill NC, Pittsburgh PA, Columbus OH,